Article info

Download PDFPDF

Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials

Authors

  • Roman Groisberg Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Unit 455, Division of Cancer MedicineThe University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd. 77030 Houston TX USA Division of Cancer MedicineThe University of Texas MD Anderson Cancer Center Houston TX USA PubMed articlesGoogle scholar articles
  • David S. Hong Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Unit 455, Division of Cancer MedicineThe University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd. 77030 Houston TX USA PubMed articlesGoogle scholar articles
  • Amini Behrang Department of Diagnostic RadiologyThe University of Texas MD Anderson Cancer Center 77030 Houston TX USA PubMed articlesGoogle scholar articles
  • Kenneth Hess Department of BiostatisticsThe University of Texas MD Anderson Cancer Center 77030 Houston TX USA PubMed articlesGoogle scholar articles
  • Filip Janku Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Unit 455, Division of Cancer MedicineThe University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd. 77030 Houston TX USA PubMed articlesGoogle scholar articles
  • Sarina Piha-Paul Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Unit 455, Division of Cancer MedicineThe University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd. 77030 Houston TX USA PubMed articlesGoogle scholar articles
  • Aung Naing Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Unit 455, Division of Cancer MedicineThe University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd. 77030 Houston TX USA PubMed articlesGoogle scholar articles
  • Siqing Fu Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Unit 455, Division of Cancer MedicineThe University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd. 77030 Houston TX USA PubMed articlesGoogle scholar articles
  • Robert Benjamin Department of Sarcoma Medical Oncology, Division of Cancer MedicineThe University of Texas MD Anderson Cancer Center 77030 Houston TX USA PubMed articlesGoogle scholar articles
  • Shreyaskumar Patel Department of Sarcoma Medical Oncology, Division of Cancer MedicineThe University of Texas MD Anderson Cancer Center 77030 Houston TX USA PubMed articlesGoogle scholar articles
  • Neeta Somaiah Department of Sarcoma Medical Oncology, Division of Cancer MedicineThe University of Texas MD Anderson Cancer Center 77030 Houston TX USA PubMed articlesGoogle scholar articles
  • Anthony Conley Department of Sarcoma Medical Oncology, Division of Cancer MedicineThe University of Texas MD Anderson Cancer Center 77030 Houston TX USA PubMed articlesGoogle scholar articles
  • Funda Meric-Bernstam Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Unit 455, Division of Cancer MedicineThe University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd. 77030 Houston TX USA PubMed articlesGoogle scholar articles
  • Vivek Subbiah Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Unit 455, Division of Cancer MedicineThe University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd. 77030 Houston TX USA PubMed articlesGoogle scholar articles
  1. a rgroisberg{at}mdanderson.org
  2. b dshong{at}mdanderson.org
  3. c BAmini{at}mdanderson.org
  4. d khess{at}mdanderson.org
  5. e FJanku{at}mdanderson.org
  6. f spihapau{at}mdanderson.org
  7. g anaing{at}mdanderson.org
  8. h siqingfu{at}mdanderson.org
  9. i rbenjami{at}mdanderson.org
  10. j spatel{at}mdanderson.org
  11. k NSomaiah{at}mdanderson.org
  12. l aconley{at}mdanderson.org
  13. m fmeric{at}mdanderson.org
  14. n 713-756-1930 VSubbiah{at}mdanderson.org
View Full Text

Citation

Groisberg R, Hong DS, Behrang A, et al
Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials

Publication history

  • Received August 10, 2017
  • Accepted November 8, 2017
  • First published December 19, 2017.
Online issue publication 
December 19, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.